We’re tracking in-house compensation. Take the Law360 Survey
Click here
September 02, 2016
Esposito v. American Renal Associates Holdings, Inc. et al
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
January 31, 2018
Private equity-backed American Renal Associates Holdings Inc. on Wednesday agreed to pay $4 million to a class of shareholders who claimed in Massachusetts federal court that the dialysis clinic operator artificially inflated its stock price and misled investors by making false statements related to allegations of insurance fraud around the time of its 2016 initial public offering.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Get instant access to the one-stop news source for business lawyers
Register Now!
Sign up now for free access to this content